【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
Regarding the recording of “Research Data” and “Evidence Data”

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

DOI Web Site Web Site 26 Citations

Search this article

CiNii Books

Journal

The Lancet

The Lancet 393 (10167), 156-167, 2019-01

Elsevier BV

Citations (26)*help

See more

Details 詳細情報について

CRID

1362262945812867968
DOI

10.1016/s0140-6736(18)31999-8
ISSN

01406736
Web Site

https://api.elsevier.com/content/article/PII:S0140673618319998?httpAccept=text/xml

https://api.elsevier.com/content/article/PII:S0140673618319998?httpAccept=text/plain
Data Source
- Crossref

Export

Report a problem

Back to top